AAV's and uses thereof
US8734809B2 · kind B2 · utility
96Cited by
23References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2010 |
| Grant date | May 27, 2014 |
| Priority date | — |
| Expiry date | May 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14145
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the invention relates to gene transfer methods using the recombinant adeno-associate viruses. In some aspects, the invention relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.